Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.
Ipratropium Bromide Nasal Solution (Nasal Spray), 0.06% (RLD Atrovent) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT November 2024). Read also: Lupin Cystic fibrosis drug gets ...
Ipratropium bromide nasal solution (nasal spray), 0.06% (Atrovent) had estimated annual sales of USD 42 million in the US (IQVIA MAT November 2024). Lupin Limited is a global pharmaceutical leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback